JP2016508789A5 - - Google Patents

Download PDF

Info

Publication number
JP2016508789A5
JP2016508789A5 JP2015556594A JP2015556594A JP2016508789A5 JP 2016508789 A5 JP2016508789 A5 JP 2016508789A5 JP 2015556594 A JP2015556594 A JP 2015556594A JP 2015556594 A JP2015556594 A JP 2015556594A JP 2016508789 A5 JP2016508789 A5 JP 2016508789A5
Authority
JP
Japan
Prior art keywords
intrauterine
layer
particulate material
core
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015556594A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016508789A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/058696 external-priority patent/WO2014122563A1/en
Publication of JP2016508789A publication Critical patent/JP2016508789A/ja
Publication of JP2016508789A5 publication Critical patent/JP2016508789A5/ja
Pending legal-status Critical Current

Links

JP2015556594A 2013-02-08 2014-01-31 膣内避妊具および該膣内避妊具における有効成分の拡散速度を減少させる方法 Pending JP2016508789A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1350155-6 2013-02-08
SE1350155 2013-02-08
PCT/IB2014/058696 WO2014122563A1 (en) 2013-02-08 2014-01-31 An intra vaginal device, and a method of reducing the rate of diffusion of active ingredients in said intra vaginal device

Publications (2)

Publication Number Publication Date
JP2016508789A JP2016508789A (ja) 2016-03-24
JP2016508789A5 true JP2016508789A5 (https=) 2017-03-09

Family

ID=50115933

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015556594A Pending JP2016508789A (ja) 2013-02-08 2014-01-31 膣内避妊具および該膣内避妊具における有効成分の拡散速度を減少させる方法

Country Status (6)

Country Link
US (2) US9775905B2 (https=)
EP (1) EP2953595B1 (https=)
JP (1) JP2016508789A (https=)
ES (1) ES2787882T3 (https=)
HU (1) HUE049219T2 (https=)
WO (1) WO2014122563A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE539540C2 (sv) 2013-09-12 2017-10-10 Qpharma Ab Ett läkemedelsavgivningssystem för en eller flera aktiva beståndsdelar
CN108135910B (zh) * 2015-05-13 2022-12-02 拜耳股份有限公司 长效药物递送装置及其在避孕中的用途
CN108392310A (zh) * 2018-02-28 2018-08-14 张晓光 免更换宫内节育器
USD935018S1 (en) * 2020-04-07 2021-11-02 The Population Council, Inc. Contraceptive
EP4215180A1 (en) * 2022-01-21 2023-07-26 Sever Pharma Solutions A drug delivery system
EP4215181A1 (en) * 2022-01-21 2023-07-26 Sever Pharma Solutions An intravaginal ring

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845761A (en) * 1970-06-02 1974-11-05 Alza Corp Intrauterine contraceptive anti-fertility device for the management of reproduction
US4069307A (en) 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US3903880A (en) * 1972-08-17 1975-09-09 Alza Corp Intrauterine device for managing the reproductive process
DD114905A5 (https=) 1973-12-06 1975-09-05
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4728478A (en) * 1982-08-05 1988-03-01 Allied-Signal Inc. Polymer films containing platelet particles
US4601714A (en) * 1983-07-07 1986-07-22 Burnhill Michael S Vaginal device
US5972372A (en) 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US6821928B2 (en) * 2001-11-06 2004-11-23 Rodney Ruskin Method to reduce the rate of diffusion of slow-release materials through polymers and process for making drip irrigation devices with long-term control of root growth
US20040213846A1 (en) * 2003-04-23 2004-10-28 Greenblatt Gary David Polymer-clay nanocomposite for extended release of active ingredient
US20060251824A1 (en) * 2005-05-05 2006-11-09 Boulais Dennis R Coating of medical devices with solids
EP2170276B1 (en) 2007-06-26 2018-08-22 Allergan Pharmaceuticals International Limited Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
EP2359807B1 (en) * 2008-02-04 2017-07-26 Ferring B.V. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
WO2013013172A1 (en) * 2011-07-20 2013-01-24 The University Of Utah Research Foundation Intravaginal devices for drug delivery
BR112014014600A2 (pt) * 2011-12-16 2017-06-13 Combinent Biomedical Systems Inc dispositivos para administração vaginal de fármacos e métodos de fabricação

Similar Documents

Publication Publication Date Title
JP2016508789A5 (https=)
CN102497855B (zh) 多层梯度的阴道环
WO2015068174A3 (en) Graphene based polymer composites for producing condoms with high heat transfer, improved sensitivity and capacity for drug delivery
CL2011002535A1 (es) Método para producir microesferas que comprenden un componente activo encapsulado al interior de una matriz de proteína de suero gelificada; y las microesferas producidas.
JP2006520751A5 (https=)
BR112012023324B8 (pt) processo de preparação de uma forma de dosagem multifásica liofilizada de dissolução rápida
US11872284B2 (en) Intrauterine device, and a method of reducing the rate of diffusion of active ingredients in said intrauterine device
JP2011504484A (ja) 膣内薬剤放出システム
JP2016534163A5 (https=)
WO2005079754A3 (en) Layered silicate nanoparticle-polymer composite medical articles
JP2012501740A5 (https=)
US20170273900A1 (en) Methods for manufacturing implants
JP2013540161A (ja) 小フィルム細片の製造
WO2010020856A3 (en) Rate modulated delivery of drugs from a composite delivery system
HRP20191217T1 (hr) Čvrsti farmaceutski sastav citizina i postupak pripreme istog
JP2016156000A5 (https=)
AR108729A1 (es) Forma farmacéutica de unidades múltiples que comprende un núcleo con unidades centrales individuales cubiertas por un material muco-adhesivo, y un recubrimiento de núcleo entérico
TW200635617A (en) Multiparticulate pharmaceutical form comprising mucoadhesively formulated nucleic acid active ingredients, and a process for producing the pharmaceutical form
FI3294300T3 (fi) Pitkävaikutteinen lääkkeenantolaite implantin tai kierukan muodossa, joka käsittää levonorgestreelia ja etinyyliestradiolia
WO2014179615A3 (en) Biodegradable copolymers, forming and using same
JP5937676B2 (ja) 二重レーンコーティング
JP2015500812A5 (https=)
Ilyes et al. THREE-DIMENSIONAL PRINTING BY FUSED DEPOSITION MODELING (3DP-FDM) IN PHARMACEUTICS.
US10912660B2 (en) Breast prostheses with phase change material
WO2015136377A3 (en) Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms